Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study
PURPOSETo evaluate the toxicity profile and efficacy of postoperative ultra-hypofractionated radiation therapy in elderly patients with breast cancer.MATERIALS AND METHODSThis is a nonrandomized, single-center, prospective Phase II trial. Patients with breast cancer older than 65 years were treated...
Saved in:
| Main Authors: | Marcel Fang, Vinicius de Carvalho Gico, Lucas Casimiro, Bruno Takatsu, Elson Santos Neto, Rossana Veronica Mendoza Lopez, Gustavo Vilela Costa Pinto, Gustavo Nader Marta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2025-04-01
|
| Series: | JCO Global Oncology |
| Online Access: | https://ascopubs.org/doi/10.1200/GO-24-00277 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01) -
Impact on outcomes of ultra hypofractionation or hypofractionation regimens and proton or Xrays therapy in a phase III randomized controlled trial MC1635
by: Carlos Vargas, et al.
Published: (2025-08-01) -
Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020–2023, using registry data and questionnaires
by: Anouk H. Eijkelboom, et al.
Published: (2025-06-01) -
Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer
by: G. V. Afonin, et al.
Published: (2018-08-01) -
Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer
by: Ana A. Díaz-Gavela, et al.
Published: (2025-03-01)